2028 Pharmacokinetics Regulations Trials 
Drug Discovery World
SEPTEMBER 26, 2022
According to MarketWatch, the drug repurposing sector was thought to be worth $25,280 in 2021 and is expected to grow to $30,620 million by 2028 with a CAGR of 2.8%. Indeed, having a safety profile already established could entice patients to enter clinical trials more readily than with ‘unknown’ compounds. . Benefits and barriers .
Drug Discovery World
AUGUST 10, 2022
And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today. For example, it is challenging to regulate transgene copy numbers in each T cell, posing safety risks. Measuring the pharmacokinetics of CAR T cells.
Expert insights. Personalized for you.
130 
Let's personalize your content